---
figid: PMC6589502__fig-3
figtitle: 'Generalized Lymphatic Anomaly and Gorham–Stout Disease: Overview and Recent
  Insights'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Danio rerio
- Homo sapiens
pmcid: PMC6589502
filename: fig-3.jpg
figlink: /pmc/articles/PMC6589502/figure/f3/
number: F3
caption: Schematic diagram summarizing the possible pathway of key elements in GSD.
  In this schema, immunological responses, related secreted cytokines, and cells are
  shown. The arrows indicate the activated directions and lateral lines indicate suppressive
  actions. The development of lesions in GSD has been associated with angiogenic and
  lymphangiogenic factors. The formation of bone lymphatics and osteoclast-mediated
  bone resorption can be seen in affected bone lesions of GSD patients. The endothelial
  cells in GSD patients highly express CD105 and activate osteal macrophages by producing
  IL-1. VEGF and TGF-β produced by osteal macrophages promote angiogenesis and lymphangiomatosis.
  CTX-1, C-terminal telopeptide of type I collagen; GSD, Gorham–Stout disease; IFN,
  interferon; IL, interleukin; OPG, osteoprotegerin; PGE2, prostaglandin E2; RANK,
  receptor activator of nuclear factor κB; RANKL, ligand for receptor activator of
  nuclear factor κB; TGF, transforming growth factor; Th, helper T; TNF, tumor necrosis
  factor.
papertitle: 'Generalized Lymphatic Anomaly and Gorham–Stout Disease: Overview and
  Recent Insights.'
reftext: Michio Ozeki, et al. Adv Wound Care (New Rochelle). 2019 Jun 1;8(6):230-245.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9737688
figid_alias: PMC6589502__F3
figtype: Figure
redirect_from: /figures/PMC6589502__F3
ndex: 12a535a1-dec2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6589502__fig-3.html
  '@type': Dataset
  description: Schematic diagram summarizing the possible pathway of key elements
    in GSD. In this schema, immunological responses, related secreted cytokines, and
    cells are shown. The arrows indicate the activated directions and lateral lines
    indicate suppressive actions. The development of lesions in GSD has been associated
    with angiogenic and lymphangiogenic factors. The formation of bone lymphatics
    and osteoclast-mediated bone resorption can be seen in affected bone lesions of
    GSD patients. The endothelial cells in GSD patients highly express CD105 and activate
    osteal macrophages by producing IL-1. VEGF and TGF-β produced by osteal macrophages
    promote angiogenesis and lymphangiomatosis. CTX-1, C-terminal telopeptide of type
    I collagen; GSD, Gorham–Stout disease; IFN, interferon; IL, interleukin; OPG,
    osteoprotegerin; PGE2, prostaglandin E2; RANK, receptor activator of nuclear factor
    κB; RANKL, ligand for receptor activator of nuclear factor κB; TGF, transforming
    growth factor; Th, helper T; TNF, tumor necrosis factor.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - thl
  - TH1
  - thi
  - thiv
  - egr
  - JIL-1
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - dpp
  - gbb
  - put
  - mav
  - pg
  - tnfb
  - th2
  - il10
  - vegfaa
  - il6
  - tnfrsf1b
  - vegfc
  - IL12A
  - IL12B
  - TCHH
  - NELFCD
  - TNF
  - IL1B
  - IL17A
  - TNFSF11
  - IL10
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - IL6
  - TGFB1
  - TGFB2
  - TGFB3
  - BTF3P11
  - TNFRSF11B
  - TNFRSF11A
---
